Description     Claims     Drawing  

WO2009092611A1   [0007] 
WO2009092612A   [0008] 
WO2012107579A   [0008] 
WO20014072526A   [0009] 
WO2014072524A   [0009]  [0055]  [0120] 
WO2015014830A   [0009]  [0055] 
WO2014072526A   [0055] 
EP2014066262W   [0120] 

Determination of the affinity of antibodies to hepatitis B surface antigen in human sera   [0166] 
Computer-assisted design of cyclic peptides and peptidomimetics   [0166] 
Hepatocellular carcinoma and hepatitis B virus   [0166] 
Structure-based design and biochemical evaluation of sulfanilamide derivatives as hepatitis B virus capsid assembly inhibitors   [0166] 
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans   [0166] 
The SLC10 carrier family: transport functions and molecular structure   [0166] 
The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions   [0166] 
Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate   [0166] 
Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat   [0166] 
Int. J. Prot. Pept. Res.   [0166] 
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein   [0166] 
Wheel of fortune - cyclic peptides hit the mimetic jackpot: current syntheses, uses and roles of cyclic peptide mimetics   [0166] 
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptide   [0166] 
An anti-viral peptide derived from the preS1 surface protein of hepatitis B virus   [0166] 
Expression and Transport Function of Drug Uptake Transporters in Differentiated HepaRG Cells   [0166] 
Inhibitors of hepatitis B virus attachment and entry   [0166] 
Use of lantibiotic synthetases for the preparation of bioactive constrained peptides   [0166] 
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody   [0166] 
The myristoylated preS1-domain of the Hepatitis B Virus L-protein mediates specific binding to differentiated hepatocytes   [0166] 
Tert-butoxycarbonylaminoacyl-4-(oxymethyl)-phenylacetamidomethyl-resin, a more acid-resistant support for solid-phase peptide synthesis   [0166] 
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development   [0166] 
Liver imaging with a novel hepatitis B surface protein derived SPECT-tracer   [0166] 
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes   [0166] 
Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes   [0166] 
Solid-Phase Synthesis of the Lipopeptide Myr-HBVpreS/2-78, a Hepatitis B Virus Entry Inhibitor   [0166] 
Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts   [0166] 
Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction   [0166] 
Hepatitis B virus infection: epidemiology and vaccination   [0166] 
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice   [0166] 
Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-Sl region of hepatitis B virus surface antigen L protein   [0166] 
Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver   [0166] 
BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly   [0166] 
Future Virol.   [0166] 
Strategies to Inhibit Entry of HBV and HDV into Hepatocytes   [0166] 
A Novel Pyridazinone Derivative Inhibits Hepatitis B Virus Replication by Inducing Genome-Free Capsid Formation   [0166] 
Contemporary strategies for peptide macrocyclization   [0166] 
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus   [0166] 
Antiviral therapy of chronic hepatitis B   [0166]